Blog

  • Researchers map a brain pathway that may signal fullness: Astrocytes emerge as a new appetite control target

    Researchers map a brain pathway that may signal fullness: Astrocytes emerge as a new appetite control target

    Scientists have identified a previously underappreciated brain signaling pathway that helps the body recognize when it is time to stop eating, shifting attention from neurons alone to a broader cellular network. The work, published April 6, 2026 in Proceedings of the National Academy of Sciences, focuses on how the hypothalamus processes post-meal fuel signals.

    The study centers on astrocytes, abundant brain cells long viewed mainly as support for neurons, and suggests they can actively shape appetite control. Researchers say this mechanism could eventually inform new strategies for obesity and eating-disorder treatments, though the findings are based on animal experiments.

    How glucose signals reach the brain

    After a meal, glucose levels rise and are sensed in part by tanycytes, specialized cells that line fluid-filled spaces in the brain. In the experiments, tanycytes responded to glucose by producing lactate, a metabolic byproduct that can function as a signaling molecule in the surrounding tissue.

    For years, lactate was often discussed as a signal that could act directly on appetite-regulating neurons. This research argues the message commonly takes an additional step, with astrocytes serving as a crucial intermediary before neurons that promote satiety are engaged.

    Astrocytes as appetite messengers

    The team found that astrocytes detect lactate via a receptor known as HCAR1 and, once activated, can release glutamate to influence nearby neurons. In this model, that astrocyte-to-neuron signal increases the excitability of POMC neurons, a population associated with suppressing appetite.

    In closely observed lab tests, stimulating glucose handling in a single tanycyte led to broader astrocyte activity nearby, suggesting the signal can spread through a local network. The researchers also described evidence consistent with a dual effect in the hypothalamus, potentially supporting satiety pathways while dampening hunger-promoting activity through separate routes.

    What this means for obesity research

    Because tanycytes and astrocytes exist across mammals, the authors argue the same kind of circuitry could plausibly operate in humans, but that remains to be confirmed. The next step, they say, is testing whether changing HCAR1 activity in astrocytes can reliably alter eating behavior.

    No approved drugs currently target this exact astrocyte pathway, and translating such findings into therapies typically requires years of follow-up work. Still, the researchers suggest that aiming at astrocyte signaling could one day complement existing anti-obesity approaches rather than replace them.

    The project reflects a long-running collaboration between the University of Concepción in Chile and the University of Maryland. The authors report the work was supported by Chilean research funding programs and the U.S. National Institutes of Health.

  • Why Waiting to Start Eating Feels Awkward: New Study Says Diners Worry More Than Their Friends Do

    Why Waiting to Start Eating Feels Awkward: New Study Says Diners Worry More Than Their Friends Do

    Restaurants and dinner hosts could make meals more enjoyable and cut down on social discomfort by ensuring everyone at the table is served at the same time, according to new research.

    Most people recognize the familiar situation at a restaurant or dinner party when one plate arrives early and the person served hesitates to start eating. This widely accepted social rule has now been examined in a study co authored by Bayes Business School. The findings show that people worry far more about breaking the rule themselves than they do about others doing so.

    Why Waiting to Eat Feels So Uncomfortable

    The research, led by Irene Scopelliti, Professor of Marketing and Behavioural Science, and Janina Steinmetz, Professor of Marketing at Bayes, along with Dr. Anna Paley from the Tilburg School of Economics and Management, explored how people judge their own behavior compared with what they expect from dining companions. The team ran six experiments to examine this difference.

    In the studies, participants imagined having a meal with a friend. Some pictured receiving their food first, while others imagined waiting as their companion was served. Those who received food first rated how strongly they felt they should wait or begin eating. Those still waiting were asked what they believed their dining partner should do.

    The results revealed a clear self other gap. People who imagined being served first felt a much stronger obligation to wait than their companions expected them to feel.

    How People Misjudge Others at the Table

    Additional experiments looked at why this mismatch occurs. Participants were asked how they would feel if their companion chose to eat or wait, and how they thought their companion would feel about their own choice. The findings showed that people expected to feel better about waiting themselves and worse about starting to eat if their food arrived first than they believed others would feel in the same situation.

    The researchers also tested whether simple interventions could change behavior. These included prompting participants to think about their companion’s perspective or telling them that the other diner had clearly invited them to start eating.

    Even with these prompts, many participants still felt uncomfortable starting to eat. The researchers suggest this helps explain why people often tell others to go ahead and eat, yet struggle to do so themselves. The findings also suggest restaurants should avoid creating situations where diners are served at noticeably different times.

    Why Politeness Often Wins Over Comfort

    Professor Steinmetz explained that deciding when to start eating with others is a common social dilemma.

    “The decision of when to start eating food in the company of others is a very common dilemma.

    “Norm adherence dictates that we wait until all food is served before starting, and disregarding it feels rude and discourteous to us. Surprisingly, this feeling barely changes even when another person explicitly asks us to go ahead. It occurs because people have greater access to their own internal feelings — such as appearing considerate or avoiding social discomfort — than to others’ psychological experiences.

    “In these situations, we should be aware that we’re only waiting for our own benefit, and co-diners probably mind far less than we think if we wanted to go ahead and eat.

    “People will wait to feel polite, but if the quality of their food is dependent on factors like temperature it may not taste as nice when they finally do start eating.”

    The Psychology Behind Social Norms

    Professor Scopelliti emphasized that the issue goes beyond simple manners.

    “This is not just about politeness: it’s about psychological access.

    “We can feel our own internal discomfort, guilt, and the positive feelings from appearing considerate, but we can’t fully access what others are experiencing internally. So, while we might feel genuinely awful about eating before others get their food, we assume others won’t feel as strongly about it.

    “Results of our study have implications for restaurants and beyond. Any service where people receive food at different times within a group creates similar psychological dynamics. Providers often optimise for efficiency, without realising that some people experience genuine discomfort when they receive service before others in their group.

    “The research shows how much we systematically underestimate others’ internal emotional experiences, which contributes to broader understanding of social norms and group dynamics.”

    The study, titled ‘Wait or Eat? Self other differences in a commonly held food norm’, by Dr. Anna Paley, Professor Irene Scopelliti and Professor Janina Steinmetz, is published in Appetite.

  • Johns Hopkins study spotlights hydrogen sulfide signaling as a potential new target in Alzheimer’s research

    Johns Hopkins study spotlights hydrogen sulfide signaling as a potential new target in Alzheimer’s research

    Researchers at Johns Hopkins Medicine report that a newly funded study by the National Institutes of Health is helping advance a potential new approach to Alzheimer’s disease treatment. The focus is a protein in the brain that produces a small but important gas.

    The protein, called Cystathionine γ-lyase, or CSE — best known for generating hydrogen sulfide, the gas that smells like rotten eggs — appears to play a key role in how memory forms. The findings come from experiments in genetically engineered mice, according to study leader Bindu Paul, M.S., Ph.D., associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine.

    The research, published in Proceedings of the National Academy of Sciences, aims to better understand how this protein works and whether boosting its activity could help protect brain cells and slow neurodegenerative diseases such as Alzheimer’s.

    Hydrogen Sulfide May Protect Brain Cells

    Earlier studies suggested that hydrogen sulfide can help protect neurons in mice. However, the gas is toxic in large amounts, which makes it unsafe to deliver directly to the brain. Scientists are instead trying to understand how to safely maintain the extremely small levels naturally present in neurons.

    The new findings show that mice engineered to lack the CSE enzyme develop problems with memory and learning. These mice also show increased oxidative stress, DNA damage and weakened blood-brain barrier integrity — all features commonly associated with Alzheimer’s disease, says Paul, the study’s corresponding author.

    Building on Years of Research

    The current work builds on earlier research led by Solomon Snyder, M.D., D.Sc., D.Phil., professor emeritus of neuroscience, pharmacology, and psychiatry. In 2014, his team reported that CSE supported brain health in mice with Huntington’s disease. The researchers used mice lacking the CSE protein, first developed in 2008 when the protein was linked to blood vessel function and blood pressure regulation.

    In 2021, the group found that CSE was not functioning properly in mice with Alzheimer’s disease, and that very small injections of hydrogen sulfide helped protect brain function.

    Those earlier studies focused on mice with additional genetic mutations tied to neurodegenerative diseases. The latest research isolates the role of CSE itself.

    “This most recent work indicates that CSE alone is a major player in cognitive function and could provide a new avenue for treatment pathways in Alzheimer’s disease,” says co-corresponding author Snyder, who retired from the Johns Hopkins Medicine faculty in 2023.

    Memory Loss Linked to CSE Deficiency

    To better understand how CSE affects memory, scientists compared mice lacking the protein with normal mice using the same strain developed in 2008. They tested spatial memory (ability to remember directions and follow cues) using a setup called the Barnes maze.

    In this test, mice learn to escape a bright light by finding a hidden shelter. At two months old, both normal mice and those lacking CSE performed similarly, locating the shelter within three minutes. By six months, however, the CSE-deficient mice struggled to find the escape route, while normal mice continued to succeed.

    “The decline in spatial memory indicates a progressive onset of neurodegenerative disease that we can attribute to CSE loss,” says first author Suwarna Chakraborty, a researcher in Paul’s lab.

    Brain Changes Mirror Alzheimer’s Disease

    The researchers also examined how the absence of CSE affects the brain at a cellular level. The hippocampus, a region critical for learning and memory, relies on the formation of new neurons. Disruptions in this process are a known feature of neurodegenerative diseases.

    Using biochemical and analytical methods, the team found that proteins involved in neurogenesis were reduced or missing in mice without CSE.

    With high powered electron microscopes, the scientists observed structural damage in the brains of these mice. They found large breaks in blood vessels, indicating harm to the blood-brain barrier, another hallmark of Alzheimer’s disease. In addition, newly formed neurons had difficulty reaching the hippocampus, where they normally contribute to memory formation.

    “The mice lacking CSE were compromised at multiple levels, which correlated with symptoms that we see in Alzheimer’s disease,” says co-first author Sunil Jamuna Tripathi, a researcher in Paul’s lab.

    Toward New Alzheimer’s Treatments

    Alzheimer’s disease affects more than 6 million people in the United States, according to the U.S. Centers for Disease Control and Prevention, and the number continues to grow. Currently, no treatments have been consistently shown to stop or slow the disease.

    The researchers say that targeting CSE and its production of hydrogen sulfide could offer a new path for developing therapies aimed at protecting brain function and slowing disease progression.

    Funding and Research Contributors

    Funding support for this research was provided by the National Institutes of Health (1R01AG071512, P50 DA044123,1R21AG073684, O1AGs066707, U01 AG073323, AG077396, NS101967, NS133688, P01CA236778), the Department of Defense (HT94252310443), the American Heart Association, AHA-Allen Initiative in Brain Health and Cognitive Impairment, the Solve ME/CFS Initiative, the Catalyst Award from Johns Hopkins University, the Valour Foundation, the Wick Foundation, Department of Veterans Affairs Merit Award (I01BX005976), the Louis Stokes Cleveland Department of Medical Affairs Veterans Center, the Mary Alice Smith Funds for Neuropsychiatry Research, the Lincoln Neurotherapeutics Research Fund, the Gordon and Evie Safran Neuropsychiatry Fund; and the Leonard Krieger Fund of the Cleveland Foundation.

    In addition to Paul, Snyder, Chakraborty and Tripathi, contributors included Richa Tyagi and Benjamin Orsburn from Johns Hopkins; Edwin Vázquez-Rosa, Kalyani Chaubey, Hisashi Fujioka, Emiko Miller and Andrew Pieper of Case Western University; Thibaut Vignane and Milos Filipovic from Leibniz Institute for Analytical Sciences, Germany; Sudarshana Sharma from Hollings Cancer Center; Bobby Thomas from Darby Children’s Research Institute and the Medical University of South Carolina, and Zachary Weil and Randy Nelson from West Virginia University School of Medicine.

  • Autism facial expressions mapped in vast new dataset, offering clues to why emotions are often misread

    Autism facial expressions mapped in vast new dataset, offering clues to why emotions are often misread

    A new study suggests autistic and non-autistic adults can express the same basic emotions with different facial movement patterns, a gap that may contribute to frequent misunderstandings in everyday interactions. Researchers say the findings support a growing view that communication difficulties can be two-way rather than rooted in a lack of emotion.

    Working with participants in both groups, scientists used detailed facial motion tracking to build a high-resolution map of how expressions for emotions such as anger, happiness and sadness are produced. The project generated more than 265 million data points, creating a large library of facial movements designed to capture subtle differences in how expressions form.

    How the researchers measured expressions

    The study involved 25 autistic adults and 26 non-autistic adults, who together produced close to 5 000 expressions under different conditions. Participants were asked to display emotions while matching facial movements to sounds and while speaking, allowing the team to examine how expressions change across contexts.

    Across tasks, autistic participants showed a wider range of unique expression patterns than their non-autistic peers, the researchers reported. For anger, the autistic group relied more on mouth movement and less on eyebrow movement, while happiness tended to be expressed with a subtler smile and sadness showed a different configuration around the upper lip.

    Alexithymia adds another layer

    The team also examined alexithymia, a trait involving difficulty identifying and describing one’s own emotions that is more common in autism than in the general population. Higher levels of alexithymia were associated with less clearly defined expressions for anger and happiness, which can make the displayed emotion appear more ambiguous.

    Lead researcher Connor Keating said the differences were not only about what expressions look like, but also how smoothly they are formed over time. Senior author Jennifer Cook argued the results fit a communication mismatch model, where both autistic and non-autistic people can misinterpret each other’s emotional signals.

    The research was published in Autism Research and was supported by the UK Medical Research Council and the EU Horizon 2020 programme. The authors said the growing dataset could help improve future studies of emotion recognition, as well as training approaches aimed at reducing everyday misreadings.

  • Depression research takes a new turn: Scientists trace the disorder to specific brain cell types

    Depression research takes a new turn: Scientists trace the disorder to specific brain cell types

    Scientists at McGill University and the Douglas Research Centre have identified specific brain cell types that show altered activity in people with major depression, a finding that could help sharpen the search for more targeted treatments.

    The work, published in Nature Genetics, combines genetic risk signals with cell-level measurements from human brain tissue to pinpoint where depression-related changes appear most strongly.

    Depression is among the world’s leading causes of disability, and many patients do not respond fully to existing therapies. Researchers have long suspected that depression involves measurable biological changes, but mapping them to precise cell types has been difficult.

    Rare brain tissue, sharper tools

    The team relied on post-mortem samples from the Douglas-Bell Canada Brain Bank, one of the specialized collections that includes tissue from people diagnosed with psychiatric conditions.

    Using single-nucleus methods, the researchers profiled gene regulation and gene activity across thousands of individual cells, comparing samples from 59 people with depression and 41 without it.

    Neurons and microglia stand out

    The analysis highlighted two cell populations with notable differences in depression: a group of excitatory neurons involved in mood and stress-related circuits, and a subtype of microglia, immune cells that help regulate inflammation in the brain.

    In both cell types, multiple genes showed altered patterns of activity, suggesting that disruptions in neural signaling and immune-related pathways may converge in the disorder.

    What this could mean for treatment

    By tying depression-associated genetic mechanisms to defined cell types, the study offers a clearer roadmap for experiments that test how these cellular shifts affect brain function over time.

    Researchers caution that the findings do not translate directly into an immediate new therapy, but they may help guide drug development and biomarker research toward more precise biological targets.

    Senior author Gustavo Turecki said the approach provides a clearer picture of where disruptions occur and which cells are involved, reinforcing the view that depression reflects identifiable brain changes rather than a purely psychological experience.

  • Study finds the brain processes speech in AI-like layers, offering new clues to how meaning is built

    Study finds the brain processes speech in AI-like layers, offering new clues to how meaning is built

    New research suggests the human brain may understand spoken language through a layered, step-by-step process that closely parallels how large language models handle text. By tracking neural activity as people listened to a continuous story, scientists found patterns that align with the progression from simpler to more complex representations seen in modern AI.

    The work, published in Nature Communications, analyzed high-temporal-resolution recordings from electrodes placed on the brain surface in clinical settings. Researchers compared the timing of neural responses with internal representations from well-known language models, including GPT-2 and Meta’s Llama 2.

    How meaning appears to unfold

    The team reports that early brain signals corresponded more closely to the earlier computational stages of AI systems that focus on basic word-level features. Later neural responses matched deeper model layers that integrate broader context, linking words into higher-level meaning.

    This alignment was especially pronounced in established language regions, including areas often associated with speech production and comprehension such as Broca’s area. In these regions, the strongest match tended to appear later in time, consistent with a gradual buildup of meaning.

    Rethinking classic language theories

    The findings add weight to the idea that comprehension is not driven primarily by rigid, rule-based structures applied instantly to each sentence. Instead, the results support a view in which the brain continuously updates interpretations as more context arrives, resembling statistical inference more than fixed symbolic parsing.

    Researchers also evaluated traditional linguistic descriptors, such as phoneme- and morpheme-level features, and found they explained real-time neural activity less effectively than the contextual features derived from AI models. That gap, the authors argue, suggests that context-rich representations may better capture how the brain tracks meaning in natural speech.

    A dataset meant to accelerate research

    Alongside the paper, the team released a public dataset designed to help other labs test competing theories of language processing against neural measurements. By pairing brain recordings with model-derived language features, the resource is intended to make comparisons across studies more consistent and reproducible.

    Experts caution that similarities do not mean the brain works the same way as today’s AI, which is trained on vast text corpora and built from artificial neural networks. Still, the results strengthen the case that AI language models can serve as useful scientific tools for probing how the brain constructs meaning over time.

  • Harvard study traces a gut bacteria link to depression, pointing to an environmental chemical that may fuel inflammation

    Harvard study traces a gut bacteria link to depression, pointing to an environmental chemical that may fuel inflammation

    Harvard Medical School researchers have outlined a new molecular pathway that may help explain why certain gut bacteria are repeatedly associated with major depressive disorder. The work centers on Morganella morganii and an immune reaction that could connect gut chemistry to brain health.

    In the study, scientists found that an environmental contaminant called diethanolamine, or DEA, can be incorporated into a lipid-like molecule produced by M. morganii in the gut. That altered molecule appears to behave differently than the standard version, shifting from relatively inert to immune-activating.

    A chemical swap with immune effects

    Laboratory tests showed the modified bacterial molecule can stimulate inflammatory signaling, including elevated release of cytokines such as interleukin-6, or IL-6. IL-6 has been widely studied as part of the broader link between inflammation and depressive symptoms in some patients.

    The authors argue this provides a clearer mechanism than earlier correlation-based microbiome findings, though it does not prove the pathway causes depression in humans. They say additional clinical work is needed to determine how often this chemistry occurs in real-world conditions and who may be most affected.

    Why inflammation matters in depression

    Inflammation has long been investigated as one contributor to depression, with evidence suggesting a subset of cases may involve immune dysregulation. The new results fit into that view by describing how a bacterial product, altered by exposure to a common industrial chemical, might intensify inflammatory signaling.

    The team also notes that M. morganii has been associated in prior research with inflammatory conditions beyond depression, including metabolic and gastrointestinal diseases. That pattern, they say, supports the idea that the bacterium’s metabolites can interact with the immune system in clinically meaningful ways.

    Potential paths for diagnosis and treatment

    The researchers suggest DEA-related chemistry could eventually help identify biological subtypes of depression, potentially using exposure markers or microbial metabolites as part of a diagnostic approach. Any such use would require validation in human cohorts and careful separation of correlation from causation.

    More broadly, the findings add momentum to efforts exploring treatments that target inflammation for selected patients, alongside established psychological and pharmacological therapies. The authors describe their work as a framework for scanning other gut microbes for similar pollutant-driven metabolic changes.

    The study was published in the Journal of the American Chemical Society and combined expertise in bacterial small-molecule chemistry and microbiome-immunity interactions. Researchers involved also highlighted the role of cross-disciplinary microbiome research in moving from broad associations toward specific, testable mechanisms.

  • Brain stimulation linked to small boost in generosity: What a new PLOS Biology study found

    Brain stimulation linked to small boost in generosity: What a new PLOS Biology study found

    Non-invasive brain stimulation that nudges two brain regions to operate in sync may slightly increase generous choices, according to a study published in PLOS Biology on February 10. Researchers say the results add evidence that specific brain-network communication can shape social decision-making.

    The international team, led by Jie Hu of East China Normal University with collaborators at the University of Zurich, tested whether coordinating activity between frontal and parietal areas affects altruism. These regions are often associated with goal-directed behavior and higher-level reasoning during complex choices.

    Testing generosity in a lab game

    The experiment included 44 participants who completed 540 rounds of a standard behavioral task known as the Dictator Game. In each round, a participant decided how to split money with another person, with the amounts varying across decisions.

    During the task, the researchers applied transcranial alternating current stimulation, a technique designed to influence brain rhythms through weak electrical currents delivered via the scalp. The goal was to encourage synchrony between the targeted frontal and parietal regions at specific oscillation frequencies.

    Gamma synchrony showed the clearest shift

    When stimulation was set to strengthen gamma-band synchrony between the two regions, participants became modestly more likely to choose larger splits for the other person. The effect was most apparent even in situations where giving more meant the participant would take less than their counterpart.

    Using computational modeling, the team reported that the stimulation appeared to change how people weighed outcomes, increasing the importance placed on the other person’s payoff. The authors described this as a measurable shift in value computations rather than a simple preference for equal splits.

    Limits and what comes next

    The researchers noted they did not directly record neural activity during stimulation, meaning the intended brain synchrony was inferred rather than confirmed in real time. They suggested future studies combining stimulation with EEG could verify how brain signals change and how long any behavioral effects last.

    Coauthor Christian Ruff said the work helps link a specific communication pattern between brain regions to altruistic choices, while Hu emphasized the study’s attempt to demonstrate cause and effect. The team cautioned that the increase in generosity was small and the findings do not imply a tool for controlling behavior outside controlled research settings.

  • Fish oil and brain injury recovery: Study flags EPA as a potential risk in repeated concussions

    Fish oil and brain injury recovery: Study flags EPA as a potential risk in repeated concussions

    A new study from the Medical University of South Carolina is raising fresh concerns about fish oil supplements, especially for people who experience repeated mild traumatic brain injuries. Writing in the journal Cell Reports, researchers report that these widely used supplements, often promoted as protective for the brain, could actually interfere with healing after injury.

    The research was led by neuroscientist Onder Albayram, Ph.D., an associate professor at MUSC and a member of the National Trauma Society Committee. His team focused on the biological processes involved in repairing blood vessels in the brain after injury.

    Rising Popularity of Omega-3 Supplements

    Interest in omega-3 fatty acids, the key components of fish oil, has been growing rapidly. According to Fortune Business Insights, these supplements are now appearing not only in capsules but also in drinks, dairy alternatives, and snack products.

    That surge in popularity does not surprise Albayram. “Fish oil supplements are everywhere, and people take them for a range of reasons, often without a clear understanding of their long-term effects,” he said.

    “But in terms of neuroscience, we still don’t know whether the brain has resilience or resistance to this supplement. That’s why ours is the first such study in the field.”

    Albayram collaborated with Eda Karakaya, Ph.D., Adviye Ergul, M.D., Ph.D., and several other researchers at MUSC and partner institutions. Among them was Semir Beyaz, Ph.D., at the Cold Spring Harbor Laboratory Cancer Center in New York.

    EPA Identified as a Potential Weak Point in Brain Recovery

    The team discovered what they describe as a context-dependent metabolic vulnerability. In simple terms, this means that changes in how cells use energy may reduce the brain’s ability to recover under certain conditions. This vulnerability appears to be linked to the buildup of eicosapentaenoic acid, or EPA, one of the main omega-3 fatty acids found in fish oil.

    In their experimental models, higher levels of EPA in the brain were associated with weaker repair after injury.

    Albayram noted that not all omega-3s behave the same way. Docosahexaenoic acid, or DHA, is well known for its beneficial role in the brain and is a major part of neuronal membranes. EPA, however, follows a different pathway. It is less incorporated into brain structures, and its effects can vary depending on how long it is present and the surrounding biological conditions. Because of this, the long-term impact of omega-3 intake on brain recovery and blood vessel adaptation has remained unclear.

    Experiments Link Diet, Brain Biology, and Recovery

    To better understand these effects, the researchers used a series of models to connect diet, brain function, and healing. In mice, they examined how long-term fish oil use influenced the brain’s response to repeated mild head impacts. Their focus was on signals related to blood vessel stability and repair.

    They also studied human brain microvascular endothelial cells, which form part of the barrier between the brain and the bloodstream. In these cells, EPA, but not DHA, was linked to reduced repair capacity, aligning with the findings from the animal models.

    To extend the findings to real-world disease, the team analyzed postmortem brain tissue from individuals diagnosed with chronic traumatic encephalopathy (CTE) who had a history of repeated brain injury.

    The researchers described the results as having “implications for precision nutrition, therapeutic strategies and the design of dietary interventions targeting brain injury and neurodegeneration.”

    Key Findings From the Study

    The study identified several major patterns, which are summarized below along with simplified explanations.

    1. EPA-driven neurovascular instability triggers perivascular tauopathy and cognitive decline following TBI.

    “In a sensitive brain state modeled in mice, long-term fish oil supplementation revealed a delayed vulnerability. The animals showed poorer neurological and spatial learning performance over time, together with clear evidence of vascular-associated tau accumulation in the cortex, linking impaired recovery to neurovascular dysfunction and perivascular tau pathology,” Albayram said.

    1. EPA reprograms cortical transcriptional responses and suppresses angiogenic signaling following traumatic brain injury.

    “In the injured cortex, the team observed a coordinated shift in gene programs that normally support vascular stability and repair,” Albayram said. “The pattern included reduced expression of genes tied to extracellular matrix organization and endothelial integrity, alongside broader changes consistent with altered lipid handling after injury.”

    1. EPA utilization under permissive metabolic conditions impairs angiogenesis and endothelial integrity, recapitulating post-traumatic brain injury cerebrovascular dysfunction.

    Albayram said that in human brain microvascular endothelial cells, EPA did not act as a universal toxin. “Instead, when cells were placed in conditions that encouraged fatty acid engagement, EPA was associated with weaker angiogenic network formation and reduced endothelial barrier integrity, matching key features of the neurovascular repair deficit seen in vivo.”

    1. CTE brain reveals neurovascular and fatty acid metabolic reprogramming consistent with EPA-linked vulnerability.

    “In postmortem cortex from neuropathologically confirmed CTE cases with a history of repetitive brain injury, the researchers found evidence of disrupted fatty acid balance and broad transcriptional changes affecting vascular and metabolic pathways,” Albayram said. “This human arm was used to provide translational context, asking whether chronic disease tissue shows convergent signatures of altered lipid handling and reduced vascular stability.”

    What the Findings Mean for Fish Oil Use

    Albayram stressed that the study should not be interpreted as a blanket warning against fish oil. “I am not saying fish oil is good or bad in some universal way,” he said. “What our data highlight is that biology is context-dependent. We need to understand how these supplements behave in the body over time, rather than assuming the same effect applies to everyone.”

    The researchers hope their work encourages a more careful look at omega-3 supplementation, both in clinical settings and among the general public. Their experiments focused on a specific scenario, repeated mild brain injury, and used CTE tissue to provide supporting observations rather than direct proof of cause and effect.

    “As with any study, there are important boundaries,” Albayram said. “In the human CTE tissue, we can observe patterns, but we cannot prove what drove them. We also cannot capture every variable that shapes omega-3 handling in real life, including overall diet, health status and lifestyle.”

    Next Steps in Understanding Omega-3 Effects

    The team plans to continue investigating how EPA moves through the body, including how it is absorbed, transported, and distributed. They are especially interested in the mechanisms that control fatty acid movement.

    “This paper is a starting point,” Albayram said, “but it is an important one. It opens a new conversation about precision nutrition in neuroscience, and it gives the field a framework to ask better, more testable questions.”

  • University of Illinois study suggests joint savoring can strengthen relationships, especially under stress

    University of Illinois study suggests joint savoring can strengthen relationships, especially under stress

    Couples who deliberately pause to appreciate enjoyable moments together tend to report stronger, more stable relationships, according to new research from the University of Illinois Urbana-Champaign. The findings suggest that this shared habit, known as joint savoring, is linked to higher satisfaction and fewer conflicts.

    Savoring is commonly described by psychologists as slowing down to notice positive experiences and letting them register, whether in the present or through remembering the past and anticipating the future. While earlier work has tied savoring to individual well-being, the Illinois team examined what changes when partners do it together.

    How joint savoring was measured

    The study analyzed survey responses from 589 adults across the United States who were in committed relationships, most of them married. Participants were asked how often they and their partners intentionally focused on positive shared experiences, using a relationship-focused measure adapted from established savoring research.

    Respondents also reported on relationship quality, including satisfaction, communication conflict, and confidence that the relationship would last. They answered separate questions about stress and well-being, capturing whether they felt on top of responsibilities or overwhelmed in the prior month.

    A buffer when stress increases

    Researchers found that people who reported more joint savoring also reported less conflict, greater relationship satisfaction, and stronger belief in their shared future. The same group also showed signs of better personal well-being, indicating potential spillover benefits beyond the relationship itself.

    The pattern was most pronounced among people experiencing higher stress, where joint savoring appeared to function as a protective factor. In other words, when pressures rose, couples who routinely focused on positive shared moments were more likely to maintain confidence in their relationship and protect mental health.

    Why small rituals may matter

    The authors argue that joint savoring is practical because it does not require major life changes, only intentional attention. They suggest couples can build it into normal routines, such as talking through a good memory, lingering over a meal, or planning something enjoyable together.

    The research also underscores a limitation common to survey-based studies: the data reflects self-reports rather than observations of both partners in real time. Still, the findings add to a growing body of evidence that simple, repeatable relationship habits can help couples stay resilient, particularly during stressful periods.